SCHEMBL435834

SCHEMBL435834

CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.69
KDM4E B2RXH2 1/20 0.69
DUSP3 P51452 1/20 0.69
MEN1 O00255 1/20 0.69
KMT2A Q03164 1/20 0.69
MAPT P10636 2/20 0.63
PRKCA P17252 4/20 0.60
PRKCE Q02156 2/20 0.60
PRKCQ Q04759 2/20 0.60
PRKCD Q05655 2/20 0.60
DGKA P23743 2/20 0.58
ALDH1A1 P00352 1/20 0.57
LPAR6 P43657 1/20 0.52
LPAR1 Q92633 1/20 0.52
LPAR4 Q99677 1/20 0.52
LPAR5 Q9H1C0 1/20 0.52
LPAR2 Q9HBW0 1/20 0.52
LPAR3 Q9UBY5 1/20 0.52
ENPP2 Q13822 1/20 0.52
MAPK1 P28482 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6877199 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL31689782 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL13106076 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL6880106 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL15435996 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL1240628 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL4230904 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL5058739 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL312968 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL313302 1.00 LMNA (0.69) LMNAKDM4EDUSP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1661 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12599152-B2 Preparation of compound rumen bypass polyunsaturated fatty acid powder and use thereof XIAMEN HUISON BIOTECH CO., LTD (CN) 2026-04-14 US claimed
EP-4477677-B1 MODIFIED POLYPROPYLENE AND A PREPARATION METHOD THEREFOR, A SEPARATOR AND A PREPARATION METHOD THEREFOR, AND A LITHIUM-SULFUR BATTERY JIANGSU ZENERGY BATTERY TECH GROUP CO LTD (CN) 2026-01-28 EP claimed
US-20250346699-A1 Modified Polypropylene and a Preparation Method Therefor, a Separator and a Preparation Method Therefor, and a Lithium-Sulfur Battery JIANGSU ZENERGY BATTERY TECH CO LTD (CN) 2025-11-13 US claimed
CN-119775983-A Degradation-controllable temporary plugging material and preparation method and application thereof 中国石油化工股份有限公司 2025-04-08 CN claimed
CN-118496584-B Modified cycloolefin copolymer and preparation method and application thereof 拓烯科技(衢州)有限公司 2025-02-18 CN claimed
CN-119463237-A Low-dielectric polyamide acid porous microsphere/polyimide composite film and preparation method thereof 电子科技大学 2025-02-18 CN claimed
US-12187866-B2 Cellulose composite film, and its preparation method SHENZHEN YUTO PACKAGING TECHNOLOGY CO., LTD. (CN) 2025-01-07 US claimed
EP-4477677-A1 MODIFIED POLYPROPYLENE AND A PREPARATION METHOD THEREFOR, A SEPARATOR AND A PREPARATION METHOD THEREFOR, AND A LITHIUM-SULFUR BATTERY Jiangsu Zenergy Battery Technologies Co., Ltd. (CN) 2024-12-18 EP claimed
CN-115279185-B Micelle disinfectant 瑞士康特股份有限公司 2024-12-06 CN claimed
CN-118496584-A Modified cycloolefin copolymer and preparation method and application thereof 拓烯科技(衢州)有限公司 2024-08-16 CN claimed
CN-1176575-A Insecticidally-active composition JOHNSON & SON INC S C (US) 1998-03-18 CN claimed
CN-1172124-A Water-absorbent resin and preparation method thereof BEIJING CHEMICAL INDUSTRY INST (CN) 1998-02-04 CN claimed
EP-0661992-A1 PHARMACEUTICAL FORMULATIONS OF INTERLEUKIN-1 INHIBITORS SYNERGEN, INC. (US) 1995-07-12 EP claimed
CN-1104484-A Nutrient cosmetics and its preparation XU BAOSHI (CN) 1995-07-05 CN claimed
CN-1097336-A Solid-shaped air-clearing agent CUI YI (CN) 1995-01-18 CN claimed
WO-1994006457-A1 PHARMACEUTICAL FORMULATIONS OF INTERLEUKIN-1 INHIBITORS SYNERGEN, INC. (US) 1994-03-31 WO claimed
CN-1076336-A Refining method for edible initial butterfat emulsion SHANGHAI INST OF PHYSIOLOGY CH (CN) 1993-09-22 CN claimed
CN-1065306-A A kind of removing of large area overflowed oil on sea, recovery method PAN GANG (CN) 1992-10-14 CN claimed
CN-1011964-B USING COMPOUND SURFACE ACTIVE AGENT COMPOSITION FOR RAISING EMULSIVE RATE HERCULES INC (US) 1991-03-13 CN claimed
CN-1004280-B Gasoline energy-saving agent and application thereof CHANGSHA RESEARCH INT OF MININ (CN) 1989-05-24 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12599152-B2 Preparation of compound rumen bypass polyunsaturated fatty acid powder and use thereof LRAT, LIPA, SCD LMNA 2132/4885KDM4E 3485/4885DUSP3 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.